哈佛生物科学 HBIO 深 沪
已收盘 02-06 16:00:00 美东时间
0.4952
+0.023
+4.92%
华盛通- 最 高0.5061
- 今 开0.483
- 成交量 17.69万股
- 最 低 0.4723
- 昨 收 0.472
- 总市值 2214.53万
- 52周最高 1.3806
- 市盈率 静 --
- 换手率 0.40%
- 52周最低 0.2813
- 委 比 -71.43%
- 总股本 4471.99万
- 历史最高 8.75
- 量 比 0.51
- 振 幅 7.16%
- 历史最低 0.2813
- 每 手 1
- 风险率 0.22%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Harvard Bioscience Trims Footprint To Run Leaner, Faster, And Cheaper
Harvard Bioscience restructures production, closing MA plant, shifting output to US and abroad. Savings expected, costs until 2027.
01-30 19:49
Harvard Bioscience Strikes Agreement With BroadOak Capital Partners To Offer $40M Credit Facility Of Three Term Loans
Harvard Bioscience, Inc. (Nasdaq: HBIO) (the "Company" or "Harvard Bioscience"), today announced it entered into an agreement with BroadOak Capital Partners (collectively, "BroadOak"), a life-sciences-focused investment
2025-12-17 20:37
Harvard Bioscience Sees Q4 Sales $22.500M-$24.500M vs $23.100M Est
Harvard Bioscience (NASDAQ:HBIO) sees Q4 sales of $22.500 million-$24.500 million vs $23.100 million analyst estimate.
2025-11-06 20:07
Harvard Bioscience Schedules Third Quarter 2025 Earnings Conference Call for November 6, 2025 at 8:00 AM ET
Harvard Bioscience, Inc. will announce its Q3 2025 financial results on November 6, 2025, before market open, followed by a conference call at 8:00 a.m. ET. Participants must register to join the call and receive dial-in details. An audio-only webcast is also available via the investor website. Financial information, including the earnings release and slides, will be accessible on the Investor Relations section of the company’s website. Harvard B...
2025-10-30 12:00
Harvard Bioscience Expands Distribution Agreement with Fisher Scientific to Include United States
Harvard Bioscience expands its distribution agreement with Fisher Scientific in the U.S., enhancing access to its lab equipment, including pumps, spectrophotometers, and BTX electroporation systems. This collaboration leverages Fisher Scientific’s extensive network and reputation, providing customers with streamlined ordering, faster delivery, and localized support. The expanded agreement simplifies procurement and ensures greater availability of...
2025-09-16 11:00
美股大行评级 | 最高400美元！大行纷纷连夜上调甲骨文目标价；新思科技则惨遭多家大行下调目标价
今日重点评级关注：瑞银：上调Gossamer Bio评级至"买入"，目标价从1.25美元升至9美元；Canaccord Genuity：维持Corcept Therapeutics"买入"评级，目标价从137美元升至140美元
2025-09-11 10:06
Benchmark Maintains Speculative Buy on Harvard Bioscience, Lowers Price Target to $2
Benchmark analyst Bruce D. Jackson maintains Harvard Bioscience (NASDAQ:HBIO) with a Speculative Buy and lowers the price target from $3 to $2.
2025-09-10 20:24
Harvard Bioscience Appoints Stephen DeNelsky to Board
Harvard Bioscience ( ($HBIO) ) just unveiled an update. On September 5, 2025, H...
2025-09-09 19:29
Harvard Bioscience Offers CFO $100K Retention Bonus
An update from Harvard Bioscience ( ($HBIO) ) is now available. On August 12, 2...
2025-08-14 05:03
